| Primary |
| Rheumatoid Arthritis |
24.8% |
| Asthma |
9.4% |
| Hypertension |
8.3% |
| Bronchitis |
5.8% |
| Ill-defined Disorder |
4.8% |
| Head And Neck Cancer |
4.3% |
| Immunosuppression |
4.3% |
| Breast Cancer |
3.7% |
| Prophylaxis Against Transplant Rejection |
3.7% |
| Ankylosing Spondylitis |
3.5% |
| Premedication |
3.4% |
| Prophylaxis |
3.4% |
| Back Pain |
3.2% |
| Pain |
2.9% |
| Glomerulonephritis Membranous |
2.8% |
| Prophylaxis Against Renal Transplant Rejection |
2.6% |
| Gastritis |
2.5% |
| Systemic Lupus Erythematosus |
2.3% |
| Inflammation |
2.2% |
| Multiple Myeloma |
2.2% |
|
| Vomiting |
10.5% |
| Drug Ineffective |
9.4% |
| Drug Hypersensitivity |
8.2% |
| Vision Blurred |
5.8% |
| Weight Decreased |
5.8% |
| Hyperglycaemia |
5.3% |
| Hypertension |
4.7% |
| Pneumonia |
4.7% |
| Urinary Tract Infection |
4.7% |
| Blood Glucose Increased |
4.1% |
| Hallucination |
4.1% |
| Rash |
4.1% |
| Tremor |
4.1% |
| Weight Increased |
4.1% |
| Diabetes Mellitus |
3.5% |
| Ileus |
3.5% |
| Nasopharyngitis |
3.5% |
| Pyrexia |
3.5% |
| Sleep Disorder |
3.5% |
| Abdominal Pain Upper |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
23.6% |
| Renal Transplant |
22.4% |
| Rheumatoid Arthritis |
13.6% |
| Hypertension |
5.9% |
| Drug Use For Unknown Indication |
4.7% |
| Asthma |
4.5% |
| Dermatomyositis |
3.4% |
| Prophylaxis Against Transplant Rejection |
2.9% |
| Prophylaxis |
2.5% |
| Gastritis Prophylaxis |
2.0% |
| Bronchitis |
1.9% |
| Constipation |
1.6% |
| Inflammation |
1.5% |
| Osteoporosis |
1.4% |
| Hyperlipidaemia |
1.4% |
| Depression |
1.3% |
| Infection Prophylaxis |
1.3% |
| Prophylaxis Against Renal Transplant Rejection |
1.3% |
| Non-hodgkin's Lymphoma |
1.3% |
| Ankylosing Spondylitis |
1.2% |
|
| Influenza |
10.8% |
| Vomiting |
9.7% |
| Urinary Tract Infection |
8.6% |
| Pneumocystis Jiroveci Pneumonia |
6.2% |
| Pyrexia |
5.7% |
| Tuberculosis |
5.4% |
| Weight Decreased |
5.4% |
| Subdural Haematoma |
5.1% |
| Tendonitis |
4.9% |
| Weight Increased |
4.6% |
| Osteonecrosis |
4.0% |
| Visual Acuity Reduced |
4.0% |
| Spinal Fracture |
3.8% |
| Rash |
3.5% |
| Pancreatitis Acute |
3.2% |
| Thirst |
3.2% |
| Back Disorder |
3.0% |
| Kidney Transplant Rejection |
3.0% |
| Pneumonia |
3.0% |
| Post Procedural Haemorrhage |
3.0% |
|
| Concomitant |
| Rheumatoid Arthritis |
19.4% |
| Product Used For Unknown Indication |
15.6% |
| Drug Use For Unknown Indication |
14.3% |
| Prophylaxis |
7.0% |
| Pain |
5.4% |
| Renal Transplant |
5.0% |
| Crohn's Disease |
4.6% |
| Hypertension |
4.2% |
| Non-small Cell Lung Cancer |
3.3% |
| Osteoporosis |
3.2% |
| Asthma |
2.9% |
| Breast Cancer |
2.0% |
| Anxiety |
1.9% |
| Nausea |
1.9% |
| Premedication |
1.9% |
| Prophylaxis Against Transplant Rejection |
1.8% |
| Psoriatic Arthropathy |
1.7% |
| Depression |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Idiopathic Thrombocytopenic Purpura |
1.4% |
|
| Vomiting |
12.5% |
| Pyrexia |
8.9% |
| Weight Decreased |
8.0% |
| Thrombocytopenia |
6.6% |
| Urinary Tract Infection |
6.6% |
| Pneumonia |
6.4% |
| Death |
4.9% |
| Lymphadenitis |
4.1% |
| Respiratory Failure |
4.0% |
| Pulmonary Embolism |
3.9% |
| Urticaria |
3.9% |
| White Blood Cell Count Increased |
3.9% |
| White Blood Cell Count Decreased |
3.6% |
| Weight Increased |
3.5% |
| Rash |
3.4% |
| Wheezing |
3.4% |
| Deep Vein Thrombosis |
3.3% |
| Sepsis |
3.2% |
| Dyspnoea |
3.1% |
| Oedema Peripheral |
2.9% |
|
| Interacting |
| Renal Transplant |
21.3% |
| Insomnia |
12.8% |
| Hypertension |
9.4% |
| Constipation |
8.5% |
| Depression |
5.1% |
| Neuralgia |
5.1% |
| Bladder Catheterisation |
4.3% |
| Hyperlipidaemia |
4.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.3% |
| Gout |
3.4% |
| Pyelonephritis |
3.0% |
| Arthropathy |
2.6% |
| Asthma |
2.6% |
| Crohn's Disease |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Inflammatory Pain |
2.6% |
| Muscle Spasms |
2.6% |
| Pulmonary Hypertension |
1.7% |
| Iridocyclitis |
0.9% |
| Juvenile Arthritis |
0.9% |
|
| Visual Impairment |
32.3% |
| Weight Increased |
12.9% |
| Myalgia |
9.7% |
| Rhinorrhoea |
9.7% |
| Pain In Extremity |
6.5% |
| Adrenal Insufficiency |
3.2% |
| Anaemia |
3.2% |
| Drug Interaction |
3.2% |
| Feeling Abnormal |
3.2% |
| Incorrect Drug Administration Duration |
3.2% |
| Injection Site Discolouration |
3.2% |
| Post Procedural Haematoma |
3.2% |
| Tachycardia |
3.2% |
| Toxicity To Various Agents |
3.2% |
|
